Department of Vascular Surgery, Shaoxing People's Hospital, Shaoxing City, China.
Department of Vascular Surgery, Shaoxing People's Hospital, Shaoxing City, China.
J Vasc Surg. 2023 Jun;77(6):1822-1832.e3. doi: 10.1016/j.jvs.2022.10.029. Epub 2022 Oct 28.
To compare the risk of mortality and complications between male and female patients undergoing aortic aneurysm repair with fenestrated-branched endovascular aortic repair (FBEVAR).
The PubMed, Embase, and Scopus databases were searched systematically for observational studies in patients undergoing elective fenestrated branched endovascular repair for aortic aneurysm. The included studies compared outcomes of interest based on the sex of the patients. The pooled effect sizes were reported as odds ratio (OR) and weighted mean difference (WMD). STATA software was used for statistical analysis.
The meta-analysis included nine studies. Compared with males, females had a higher risk of perioperative and in-hospital mortality (OR, 3.01; 95% confidence interval [CI], 2.01-4.53), mortality within 1 year postoperatively (OR, 1.79; 95% CI, 1.09-2.93) and mortality at more than 1 year postoperatively (OR, 1.31l 95% CI, 1.02-1.69). Female patients had significantly higher operative time (minutes) (WMD, 33.77; 95% CI, 12.01-55.52), length of hospital stay (days) (WMD, 2.29; 95% CI, 1.52-3.07), and the risk of major complications (OR, 2.93; 95% CI, 1.36-6.32) There was an increased risk of respiratory complications (OR, 1.70; 95% CI, 1.20-2.40), renal complications (OR, 2.68; 95% CI, 1.25-5.74), stroke (OR, 2.74; 95% CI, 1.44-5.22), sepsis (OR, 2.24; 95% CI, 1.23-4.09), and ischemic colitis (OR, 2.63; 95% CI, 1.48-4.68) in female patients, and they were less likely to be discharged home postoperatively (OR, 0.58; 95% CI, 0.43-0.77).
In patients undergoing FBEVAR, female sex is associated with higher risk of mortality and complications. These findings suggest the need for careful supervision and management by multidisciplinary team in females undergoing FBEVAR.
比较采用开窗分支腔内血管修复术(FBEVAR)治疗主动脉瘤的男性和女性患者的死亡率和并发症风险。
系统检索 PubMed、Embase 和 Scopus 数据库中关于接受择期 FBEVAR 治疗主动脉瘤的患者的观察性研究。纳入的研究根据患者的性别比较了感兴趣的结局。汇总效应大小以比值比(OR)和加权均数差(WMD)表示。采用 STATA 软件进行统计分析。
荟萃分析纳入了 9 项研究。与男性相比,女性围手术期和住院死亡率(OR,3.01;95%置信区间[CI],2.01-4.53)、术后 1 年内死亡率(OR,1.79;95%CI,1.09-2.93)和术后 1 年以上死亡率(OR,1.31;95%CI,1.02-1.69)更高。女性患者的手术时间(分钟)(WMD,33.77;95%CI,12.01-55.52)、住院时间(天)(WMD,2.29;95%CI,1.52-3.07)和主要并发症风险(OR,2.93;95%CI,1.36-6.32)更高。女性发生呼吸系统并发症(OR,1.70;95%CI,1.20-2.40)、肾脏并发症(OR,2.68;95%CI,1.25-5.74)、中风(OR,2.74;95%CI,1.44-5.22)、败血症(OR,2.24;95%CI,1.23-4.09)和缺血性结肠炎(OR,2.63;95%CI,1.48-4.68)的风险更高,术后更不可能出院回家(OR,0.58;95%CI,0.43-0.77)。
在接受 FBEVAR 治疗的患者中,女性性别与更高的死亡率和并发症风险相关。这些发现表明,在接受 FBEVAR 的女性中,需要多学科团队进行仔细的监督和管理。